Ken Griffin Bruker Corp Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bruker Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 28,100 shares of BRKR stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,100
Previous 29,700
5.39%
Holding current value
$1.82 Million
Previous $2.18 Million
20.94%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding BRKR
# of Institutions
404Shares Held
100MCall Options Held
211KPut Options Held
14.5K-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.3MShares$862 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.86MShares$640 Million0.02% of portfolio
-
Black Rock Inc. New York, NY9.71MShares$631 Million0.02% of portfolio
-
Pallas Capital Advisors LLC Braintree, MA9.48MShares$616 Million38.49% of portfolio
-
Massachusetts Financial Services CO Boston, MA8.09MShares$525 Million0.24% of portfolio
About BRUKER CORP
- Ticker BRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 148,138,000
- Market Cap $9.62B
- Description
- Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...